Japanese pediatric guidelines for the treatment and management of bronchial asthma 2008: Japan Today

Pediatrics International

Volumn 52, Issue 2, 2010, Pages 319-326

  Kondo, Naomi ^a,b   Nishimuta, Toshiyuki ^b,c   Nishima, Sankei ^b,d   Morikawa, Akihiro ^b,e   Aihara, Yukoh ^b   Akasaka, Toru ^b   Akasawa, Akira ^b   Adachi, Yuichi ^b   Arakawa, Hirokazu ^b   Ikarashi, Takao ^b   Ikebe, Toshiichi ^b   Inoue, Toshishige ^b   Iwata, Tsutomu ^b   Urisu, Atsuo ^b   Ebisawa, Motohiro ^b   Ohya, Yukihiro ^b   Okada, Kenji ^b   Odajima, Hiroshi ^b   Katsunuma, Toshio ^b   Kameda, Makoto ^b   Kurihara, Kazuyuki ^b   Kohno, Yoichi ^b   Sakamoto, Tatsuo ^b   Shimojo, Naoki ^b   Suehiro, Yutaka ^b   Tokuyama, Kenichi ^b   Nambu, Mitsuhiko ^b   Hamasaki, Yuhei ^b   Fujisawa, Takao ^b   Matsui, Takehiko ^b   Matsubara, Tomoyo ^b   Mayumi, Mitsufumi ^b   Mukoyama, Tokuko ^b   Mochizuki, Hiroyuki ^b   Yamaguchi, Koichi ^b   Yoshihara, Shigemi ^b   more..

^a GIFU UNIVERSITY   (Japan)

^b Japanese Society of Pediatric Allergy and Clinical Immunology   (Japan)

^c SHIMOSHIZU HOSPITAL   (Japan)

^d FUKUOKA NATIONAL HOSPITAL   (Japan)

^e GUNMA UNIVERSITY   (Japan)

Author keywords

Acute attacks; Childhood asthma; Guideline; Long term management; Prevention

Indexed keywords

AMINOPHYLLINE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; ISOPRENALINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OXYGEN; SALBUTAMOL; THEOPHYLLINE;

AGE; ARTIFICIAL VENTILATION; ASTHMA; CHILD DEATH; CHILD HEALTH CARE; CONTINUOUS INFUSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG RESPONSE; EARLY INTERVENTION; EVENING DOSAGE; EXERCISE INDUCED ASTHMA; HOME CARE; HUMAN; JAPAN; LONG TERM CARE; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; MORNING DOSAGE; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REPEATED DRUG DOSE; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SEVERE PERSISTENT ASTHMA; TREATMENT PLANNING; ADOLESCENT; CHILD; INFANT; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; TIME;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 77950246487     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2009.03010.x     Document Type: Review

References (24)

1. Japanese Society of Allergy and Clinical Immunology. Japanese Pediatric Guidelines for the Treatment and Management of Asthma 2008, 1st edn. Kyowa Kikaku, Tokyo, 2008.
2. Japanese Society of Allergy and Clinical Immunology. Japanese Pediatric Guidelines for the Treatment and Management of Asthma 2005, 1st edn. Kyowa Kikaku, Tokyo, 2005.
3. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Revised 2006. Medical Communications Resources Inc, 2006.
4. Morikawa A, Nishima S, Japanese Society of Pediatric Allergy and Clinical Immunology. New Japanese pediatric guidelines for the treatment and management of bronchial asthma. Pediatr. Int. 2007 49 : 1023 1031.
5. Frank TL, Adisesh A, Pickering AC et al. Relationship between exhaled nitric oxide and childhood asthma. Am. J. Respir. Crit. Care Med. 1998 158 : 1032 1036.
6. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: Relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982 37 : 423 429.
7. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence on symptoms of asthma, allergic rhino-conjunctivitis, and atopic eczema: ISAAC. Lancet 1998 351 : 1225 1232.
8. Nishima S, Odajima H. Prevalence of childhood allergic diseases in Japan using interstitial study of asthma and allergies in childhood (ISAAC) phase I protocol. Jpn. J. Pediatr. Allergy Clin. Immunol. 2002 16 : 207 220.
9. Study Group of the Prevalence of Allergic Diseases, West Japan Study Group of Allergy in Children. A study on the prevalence of allergic diseases in school children in western districts of Japan: Comparison between the studies in 1992 and 2002 with the same methods and same districts. Jpn. J. Pediatr. Allergy Clin. Immunol. 2003 17 : 255 268.
10. Nishima S, Chisaka H, Fujiwara T et al. Surveys on the prevalence of pediatric bronchial asthma in Japan: a comparison between the 1982, 1992, and 2002 surveys conducted in the same region using the same methodology. Allergol. Int. 2009 58 : 37 253.
11. Hanrahan JP, Tager IB, Segal MR et al. The effect of maternal smoking during pregnancy on early infant lung function. Am. Rev. Respir. Dis. 1992 145 : 1129 1135.
12. Weiss ST, Tager IB, Munoz A, Speizer FE. The relationship of respiratory infections in early childhood to the occurrence of increased levels of bronchial responsiveness and atopy. Am. Rev. Respir. Dis. 1985 131 : 573 578.
13. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. GINA2002. National Institute of Health, National Heart, Lung, and Blood Institute, Bethesda, 2002.
14. Iikura Y, Matsumoto T, Fujita K et al. Continuous isoproterenol inhalation therapy in children with severe asthmatic attack. Int. Arch. Allergy Immunol. 1997 113 : 370 372.
15. Nishimuta T, Watanabe H, Sato K et al. A study on the usefulness of the Japanese pediatric asthma control program (JPAC). J. Pediatr. Allergy Clin. Immunol. 2008 22 : 135 145.
16. Itazawa T, Adachi Y, Ito Y et al. [Bronchial Asthma - Long term management: A study on the usefulness of the Childhood Asthma Control Test (C-ACT)]. Jpn. J. Allergol. 2007 56 : 1055 (in Japanese).
17. Leung KB, Flint KC, Brostoff J et al. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 1988 43 : 756 761.
18. Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J. Allergy Clin. Immunol. 2002 109 : 257 263.
19. EBM Task Force. Guideline Committee of the Japanese Society of Pediatric Allergy and Clinical Immunology. Effects of tulobuterol patch on airway hypersensitivity in children with bronchial asthma: A multicenter, double-blind double-dummy comparative study. Jpn. J. Pediatr. Allergy Clin. Immunol. 2003 17 : 204 209.
20. Hershenson MB, Colin AA, Wohl ME, Stark AR. Changes in the contribution of the rib cage to tidal breathing during infancy. Am. Rev. Respir. Dis. 1990 141 : 922 925.
21. Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. BMJ 1982 284 : 1665 1669.
22. Kemp JP, Dockhorn RJ, Shapiro GG et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6-14 year-old children with asthma. J. Pediatr. 1998 133 : 424 428.
23. Nishima S. Treatment and management of severe asthma in childhood through to young adult patients. Allergol. Int. 2001 50 : 249 264.
24. Committee on Asthma Death in Japanese Children, The Japanese Society of Pediatric Allergy and Clinical Immunology. Asthma death in Japanese children. Committee report in 2002. Jpn. J. Periatr. Allergy Clin. Immunol. 2003 17 : 290 303.